Local IGF-1 and Akt/mTOR signaling in skeletal muscle of lubabegron-supplemented finishing steers.

Authors

Donghun Kang, Byungkyoo Park, Erika P Eckhardt, Anna M Munger, Andrea M Luttman, Andrea Garmyn, Nathan Pyatt, Jongkyoo Kim

Published in

Journal of animal science. Sep 02, 2026. Epub Sep 02, 2026.

Abstract

Lubabegron (LUB) is a β-adrenergic agonist/antagonist approved for reduction of ammonia gas emissions in feedlot cattle; improvements in growth and carcass yield have also been reported, although the underlying mechanism remains unresolved. Thirty-two Angus-influenced steers (524 ± 5 kg) were assigned to control (CON) or LUB diets (3.5 mg/kg DM; targeted 36 mg/steer/d for 63 d). All steers had received a trenbolone acetate-estradiol implant (TE-200) at arrival, 58 d before treatment initiation, administered identically across groups. Growth performance, carcass traits, longissimus muscle (LM) composition, transcriptome, signaling protein abundance, and IGF-1 were measured. LUB increased final BW (637 vs. 612 kg), ADG, DMI, and gain-to-feed ratio relative to CON (P < 0.01). Hot carcass weight was 18.5 kg greater in LUB (P < 0.01), whereas dressing percentage, ribeye area, 12th-rib fat, and marbling score were unaffected (P ≥ 0.25). LM crude protein was higher (23.6 vs. 22.5%; P < 0.01) and crude fat tended lower (5.0 vs. 6.4%; P = 0.051) in LUB steaks. Warner-Bratzler shear force was greater in LUB at 2 d (4.36 vs. 3.67 kg; P = 0.03) and 14 d (3.74 vs. 2.76 kg; P < 0.01) postmortem. Serum creatinine, total protein, bilirubin, and cholesterol were elevated in LUB steers (P ≤ 0.02). Transcriptomic profiling at day 56 identified 643 differentially expressed genes, with upregulation of myogenic regulators, glycolytic enzymes, and fast-twitch fiber genes and downregulation of adipogenic networks. Phospho-mTOR abundance (P = 0.03) and the p-mTOR/mTOR ratio (P = 0.05) were greater in LUB. Although LUB is an established β3-AR agonist, receptor binding and protein abundance were not assessed; β3-AR transcript in LM was minimal and undetectable in 40.6% of samples, and neither p-CREB nor the p-CREB/CREB ratio differed between treatments (P ≥ 0.32), arguing against p-CREB-dependent β3-AR signaling as the primary driver. IGF-1 protein in LM was greater in LUB-supplemented steers at day 56 (P = 0.01), whereas circulating IGF-1 did not differ overall (P = 0.66), although a treatment × time interaction was detected (P < 0.05). The dissociation between elevated local muscle IGF-1 and the absence of a sustained systemic increase supports an autocrine and paracrine IGF-1 mechanism with downstream Akt/mTOR activation as a coherent framework for the muscle response observed with LUB supplementation.

PMID:
42684050
Bibliographic data and abstract were imported from PubMed on 02 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.